Plain-English translation of NCT06635564 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial examined three different devices—ClotPro, ROTEM delta, and TEG 6s—that measure how well blood clots during surgery. Researchers tested these devices in three groups of vulnerable patients: those having liver surgery, brain surgery, or cesarean delivery. The goal was to figure out which device gives the fastest and most accurate results to help doctors prevent dangerous bleeding during these high-risk procedures.
During major surgery, doctors need to quickly know whether a patient's blood is clotting properly so they can safely manage bleeding. Currently, doctors don't have a clear, personalized way to use clotting tests to make these decisions. This trial aimed to determine which clotting measurement device is most reliable and fast, so doctors can better protect patients from bleeding complications.
Participants in this trial had blood samples collected using three different clotting measurement devices before, during, and after their scheduled surgery. The devices tested how quickly and effectively blood was clotting to help doctors decide whether additional blood products or medications were needed. The trial collected information from 240 patients across the three surgery types to compare how well each device performed and whether results predicted bleeding or clotting problems.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Austria